Agilvax
Private company that discovers and develops immunotherapies to combat cancer & targeted vaccines against infectious diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
$6—9m (Dealroom.co estimates Jan 2020.)
Albuquerque New Mexico (HQ)
Authorizing premium user...